CLINICAL_TRIALS
trial_result
· 2022-06-06
Clinical Trial Update: Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C [Phase 2]
Summary
Phase 2 trial evaluating ezetimibe for chronic hepatitis C; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Chronic Hepatitis C | Phase 2 | Status: TERMINATED | Results posted: 2022-06-06